Considering TWEAK as a target for therapy in renal and vascular injury
- 30 June 2009
- journal article
- review article
- Published by Elsevier BV in Cytokine & Growth Factor Reviews
- Vol. 20 (3), 251-258
- https://doi.org/10.1016/j.cytogfr.2009.05.002
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Additive Effects of Soluble TWEAK and Inflammation on Mortality in Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2009
- The Cytokine TWEAK Modulates Renal Tubulointerstitial InflammationJournal of the American Society of Nephrology, 2008
- Role of TWEAK and Fn14 in tumor biologyFrontiers in Bioscience-Landmark, 2007
- TWEAK and Fn14. New players in the pathogenesis of atherosclerosisFrontiers in Bioscience-Landmark, 2007
- Cytokine cooperation in renal tubular cell injury: The role of TWEAKKidney International, 2006
- Fn14 Is Upregulated in Cytokine-Stimulated Vascular Smooth Muscle Cells and Is Expressed in Human Carotid Atherosclerotic PlaquesStroke, 2006
- Paracetamol-Induced Renal Tubular InjuryJournal of the American Society of Nephrology, 2004
- TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-κB through TNF receptor-associated factorsBiochemical and Biophysical Research Communications, 2003
- Resistance to the Cytotoxic Effects of Tumor Necrosis Factor α Can Be Overcome by Inhibition of a FADD/Caspase-dependent Signaling PathwayPublished by Elsevier BV ,1999
- The Nuclear Factor κ-B Signaling Pathway Participates in Dysregulation of Vascular Smooth Muscle Cells in Vitroand in Human AtherosclerosisPublished by Elsevier BV ,1997